Lv1
100 积分 2024-01-10 加入
The effects of GIP, GLP-1 and GLP-2 on markers of bone turnover: a review of the gut-bone axis
16小时前
已完结
RIPK1 and necroptosis role in premature ageing
27天前
已完结
From RIPK1 to Necroptosis: Pathogenic Mechanisms in Neurodegenerative Diseases
28天前
已完结
RIPK1: A Promising Target for Intervention Neuroinflammation
28天前
已完结
A novel gut-restricted RIPK1 inhibitor, SZ-15, ameliorates DSS-induced ulcerative colitis
1个月前
已完结
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
1个月前
已完结
Systematic review with meta‐analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases
3个月前
已完结
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
3个月前
已完结
P019 GS-1069518 is a potent and selective small molecule α4β7 inhibitor
3个月前
已关闭
Understanding the therapeutic toolkit for inflammatory bowel disease
3个月前
已完结
皖公网安备34019202002308
